COMPARATIVE EFFICACY AND SAFETY OF LIXISENATIDE AND INSULIN REGIMENS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY BASAL INSULIN: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引：0
|
作者：
Men, P. [1 ]
Qu, S. [2 ]
Luo, W. [2 ]
Liu, Y. [3 ]
Li, C. [4 ]
Zhai, S. [1 ]
机构：
[1] Peking Univ, Hosp 3, Dept Pharm, Beijing, Peoples R China
[2] IQVIA, Shanghai, Peoples R China
[3] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[4] Sanofi, Shanghai, Peoples R China
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.269
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB4
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [1] Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal insulin: Systematic review, network meta-analysis and cost-effectiveness analysis
    Men, Peng
    Qu, Shuli
    Luo, Wenting
    Li, Chaoyun
    Zhai, Suodi
    DIABETES OBESITY & METABOLISM, 2020, 22 (01): : 107 - 115
  • [2] SAFETY AND EFFICACY OF INSULIN GLARGINE/LIXISENATIDE AND INSULIN DEGLUDEC/INSULIN ASPART IN TYPE 2 DIABETES PATIENTS NOT CONTROLLED ON BASAL INSULIN: A NETWORK META-ANALYSIS
    Jammah, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A185 - A186
  • [3] COST-EFFECTIVENESS OF LIXISENATIDE COMBINED WITH BASAL INSULIN VERSUS INSULIN REGIMENS FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY BASAL INSULIN IN CHINA
    Men, P.
    Qu, S.
    Luo, W.
    Li, C.
    Zhai, S.
    VALUE IN HEALTH, 2019, 22 : S150 - S150
  • [4] Cost-effectiveness of lixisenatide combined with basal insulin versus insulin regimens for the treatment of patients in China with type 2 diabetes mellitus inadequately controlled by basal insulin
    Men, Peng
    Qu, Shuli
    Luo, Wenting
    Li, Chaoyun
    Zhai, Suodi
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [5] LIXISENATIDE, BASAL INSULIN AND PREMIXED INSULIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY ORAL ANTIDIABETIC DRUGS: NETWORK META-ANALYSIS AND COST-EFFECTIVENESS ANALYSIS
    Men, P.
    Qu, S.
    Li, C.
    Zhai, S.
    VALUE IN HEALTH, 2019, 22 : S150 - S150
  • [6] Lixisenatide plus basal insulin in patients with type 2 diabetes mellitus: a meta-analysis
    Charbonnel, Bernard
    Bertolini, Monica
    Tinahones, Francisco J.
    Puig Domingo, Manuel
    Davies, Melanie
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 880 - 886
  • [7] Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis
    Dawoud, Dalia
    O'Mahony, Rachel
    Wonderling, David
    Cobb, Jill
    Higgins, Bernard
    Amiel, Stephanie A.
    VALUE IN HEALTH, 2018, 21 (02) : 176 - 184
  • [8] Efficacy and safety of combination of semaglutide and basal insulin in patients with of type 2 diabetes mellitus: A systematic review and meta-analysis
    Chen, Binbin
    Tao, Lanqiu
    Tian, Min
    Ji, Zhaohua
    CLINICAL NUTRITION ESPEN, 2025, 66 : 564 - 572
  • [9] Comparison of the efficacy and safety of basal insulin-based regimens and premixed insulin-based regimens in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
    Bi, Yan
    Gu, Tianwei
    Grijalva, Ambar
    Murray, Erin
    del Aguila, Michael
    Li, Yunguang
    Lu, Hai
    Cui, Nan
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [10] Meta-Analysis of Randomized Controlled Trials of Lixisenatide as Add-On to Basal Insulin in Patients With Type 2 Diabetes Mellitus
    Charbonnel, Bernard
    Wang, Edward
    Lin, Jay
    Davies, Melanie
    Fonseca, Vivian
    DIABETES, 2013, 62 : A270 - A270
12345